High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults-Reference-Cited by-同舟云学术

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

Published:2008-01-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Greb Alexander¹,Bohlius Julia²,Schiefer Daniel³,Schwarzer Guido⁴,Schulz Holger⁵,Engert Andreas⁵

Affiliation:

1. Carl Schurz Strasse 8 Cologne Germany 50935

2. University of Bern; Institute of Social and Preventive Medicine; Bern Switzerland 3012

3. University Hospital Ulm; Department of Internal Medicine II; Steinhoevelweg 9 Ulm Germany D-89070

4. Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg; German Cochrane Centre; Stefan-Meier-Str. 26 Freiburg Germany D-79104

5. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

Publisher

Wiley

Subject

Pharmacology (medical)

Reference136 articles.

1. De Souza CA Baldissera RC Simoes BP Maiolino A Moraes AAJG Ruiz MA Unselected High-Risk IPI NHL Presented a High Early Mortality Rate in a prospective Randomized Study Comparing Conventional Chemotherapy and High-Dose Escalation Followed by Autologous Bone Marrow Transplantation Blood 2001 391b

2. Gianni AM Bregni M Siena S Brambilla C Di Nicola M Lombardi F Gandola L Tarella C Pileri A Stern A Valagussa P Bonadonna G Is high-dose better than standard dose chemotherapy as initial treatment of poor risk large cell lymphomas? A critical analysis from available randomized trials [abstract] Annals of Oncology 1996 12 19

3. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma;Gianni;New England Journal of Medicine,1997

4. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma;Gisselbrecht;Journal of Clinical Oncology,2002

5. Gisselbrecht C Lepage E Morel P Lederlin P Coiffier B Tilly H Bosly A Gabarre J Briere J Fillet G Molina T Reyes F Failure of early autologous stem cell transplantation in poor risk patients with aggressive lymphoma: updated results of the LNH93-3 study [abstract] Annals of Hematology 2001 B157 26

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma;Experimental Hematology & Oncology;2024-01-03

2. The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma;Cancer Reports;2023-02-28

3. Short- and long-term outcomes from the upfront high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation in diffuse large B-cell lymphoma;Meditsinskiy sovet = Medical Council;2022-06-19

4. Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data;BMJ Medicine;2022-06

5. Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study;Therapeutic Advances in Hematology;2022-01